NANOBIOTIX strengthens its management team
(Thomson Reuters ONE) -
Small but heading for a big time
Appointment of Philippe MAUBERNA, CFO of Nanobiotix (since May 2013) to the
Executive Board and creation of a Communications and Public Affairs Department
headed by Sarah Gaubert
Paris, France, 23 September, 2013 - NANOBIOTIX (Euronext: NANO), a clinical-
stage nanomedicine company pioneering novel approaches for the local treatment
of cancer, announces today the strengthening of its management team to support
the company's growth within its business strategy.
1. Appointment of Philippe MAUBERNA, CFO of Nanobiotix since the end of May
2013 to the Executive Board by the Supervisory Board effective from August
28, 2013
As expert in management and development of financial and operational projects
for the pharmaceutical industry, Philippe MAUBERNA (ISG-INSEAD), has been
involved in several international projects (UK, Saudi Arabia, South Africa and
Indonesia). Dedicated to the Life Sciences industry for more than 10 years, he
has held senior Financial and Operations positions at Astellas Pharma Europe
participating in the reinforcement of EMEA commercial effectiveness in Africa
and in Europe, most notably this was supporting market authorization for several
healthcare products.
He has also been heavily involved in financial projects for start-up launches
and innovative SME development. As a consultant, he has provided strategic
change management support for European pharmaceutical companies during their
development phases.
2. Creation of a Communication and Public Affairs Department headed up by Sarah
Gaubert
Formerly advisor to the French Presidency and to several Ministries (Health,
Solidarity, Education and Research), Sarah GAUBERT, consultant in strategic
communications, heads Nanobiotix' newly created Communication and Public Affairs
Department.
"In order to meet our corporate governance requirements, there was a strong need
to strengthen and structure the management team. Based on our business needs,
Philippe Mauberna has the right mix of experience and competencies which will be
key in supporting our growth. As a public company, we have the increasing
responsibility to have a transparent and coordinated communication on our
ambitious plans. This will be the challenge for Sarah Gaubert, expert in public
and parliamentary affairs, who shares with the Nanobiotix team the notion of
general interest and transmission" said Laurent Levy, CEO of Nanobiotix.
About NANOBIOTIX
Nanobiotix (Euronext: NANO / ISIN: FR0011341205) is a clinical-stage
nanomedicine company pioneering novel approaches for the local treatment of
cancer. The Company's first-in-class, proprietary technology, NanoXray, enhances
radiotherapy energy to provide a new, more efficient treatment for cancer
patients. NanoXray products are compatible with current radiotherapy treatments
and are meant to treat a wide variety of cancers via multiple routes of
administration. Nanobiotix's lead product NBTXR3, based on NanoXray, is
currently under clinical development for soft tissue sarcoma. The Company, based
in Paris, France. has partnered with PharmaEngine for clinical development and
commercialization of NBTXR3 in Asia.
Laurent Levy, CEO and co-founder of Nanobiotix, is the Vice-President of the
European Technology Platform of Nanomedicine (ETPN).
For more information, please visit www.nanobiotix.com
For more information, please contact:
Nanobiotix Yucatan
Sarah Gaubert Media relations (France)
Head of Communication Annie-Florence Loyer/ Nadège Le Lezec
and Public Affairs +33 (0)1 53 63 27 27 / +33 (0)6
88 20 35 59
+33 (0)1 40 26 07 55
afloyer(at)yucatan.fr
contact(at)nanobiotix.com
NewCap. College Hill
Financial communication Media relations (Outside France)
and investors relations
Melanie Toyne Sewell / Donia Al Saffar
Louis-Victor Delouvrier / Emmanuel
Huynh +44 (0) 207 457 2020
+33 (0)1 44 71 98 53 nanobiotix(at)collegehill.com
lvdelouvrier(at)newcap.fr
NANOBIOTIX stenghtens its management team:
http://hugin.info/157012/R/1730655/578408.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: NANOBIOTIX via Thomson Reuters ONE
[HUG#1730655]
Datum: 23.09.2013 - 08:16 Uhr
Sprache: Deutsch
News-ID 298964
Anzahl Zeichen: 5698
contact information:
Town:
Paris
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 122 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"NANOBIOTIX strengthens its management team"
steht unter der journalistisch-redaktionellen Verantwortung von
NANOBIOTIX (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
